Co-mutational status and PD-L1 expression in <i>KRAS</i> mutant non-small cell lung cancer (NSCLC): Role in treatment selection and association with clinical outcomes.

Hina Khan, Nagla Fawzy Abdel Karim, Girindra Raval et al.|Journal of Clinical Oncology|2023

Cited by 2